Author name: comtex

The Gross Law Firm issues the following notice to shareholders of Reckitt Benckiser Group plc (OTCQX: RBGLY). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of RBGLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: […]

The Gross Law Firm issues the following notice to shareholders ofFortrea Holdings Inc. (NASDAQ: FTRE). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of FTRE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Fortrea Holdings

For 30 years, web browsers have been passive windows to the internet, leaving users to perform the actual work of navigating, copying, and pasting between countless tabs and apps. Opera [NASDAQ: OPRA], the web pioneer, is tackling this fundamental inefficiency with a new vision for browsing: the proactive, agentic browser that gets things done for

Huaya Times (åé'…•æ-䔣), a project invested by Pop Culture Group Co., Ltd. (Nasdaq: CPOP), officially launched on July 24, 2025. The project introduces a new residential product, “Huaya Times,” by Budian Home, presenting a groundbreaking solution for the modern living revolution. Huaya Times pioneers an innovative “20-year long-term lease + fixed low-rent residency rights” model,

Fortis Inc. Announces Third Quarter Dividends – 2025 GlobeNewswire July 31, 2025 ST. JOHN'S, Newfoundland and Labrador, July 31, 2025 (GLOBE NEWSWIRE) — This news release constitutes a “Designated News Release” incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024. The Board

(NASDAQ:PALI), PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn's disease (FSCD) and ulcerative colitis (UC), to address significant unmet medical needs Inflammatory Bowel Disease is a large and growing market opportunity in China, with forecasts approaching $1B in total revenues by 2030 Carlsbad, CA, July

Palisade Bio Receives Notice of Allowance for Composition of Matter Patent Covering Lead Product Candidate PALI-2108 in China GlobeNewswire July 31, 2025 PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn's disease (FSCD) and ulcerative colitis (UC), to address significant unmet medical needs Inflammatory Bowel Disease

Today, Tieton Cider Works, the eighth fastest growing cider brand in the US via Nielsen, is thrilled to announce that their Imperial Magic Berry 4 pk (16 oz) will be hitting Costco shelves this week across all WA, OR, ID, MT and AK locations. The news is truly expansive for the business, as it signifies

(NasdaqGM:SUPN),(NasdaqGM:SAGE), ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition of Sage Therapeutics, Inc. (Nasdaq: SAGE) (“Sage”). “Sage is an ideal fit in our corporate development strategy, adding a significant fourth growth product to our portfolio and further diversifying

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics Acquisition strengthens Supernus' leading presence in neuropsychiatric conditions with an innovative commercial product, ZURZUVAE(R) (zuranolone), and a novel CNS discovery platform, accelerating mid- to long-term revenue and cash flow growth and further diversifying revenue base GlobeNewswire July 31, 2025 ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) — Supernus